Answers are grounded in this paper and cite their sources.
Background Chronic immune thrombocytopenia (ITP) in children can cause recurrent bleeding, prolonged follow-up, and increased treatment exposure. This study assessed whether the 4-week platelet count rise rate after diagnosis was independently associated with chronicity at 12 months and explored its threshold performance for early risk stratification. Methods This single-center retrospective study included 335 children aged <18 years with newly diagnosed primary ITP from January 2018 to December 2023. The platelet count rise rate was calculated as the average weekly increase from diagnosis to the 4-week assessment (×10 9 /L/week). Chronicity was defined as platelet count <100 × 10 9 /L at 12 months, ITP-related treatment at 12 months, or ITP-related treatment within the preceding 4 weeks. Independent associations were examined using multivariable logistic regression and quartile trend analysis. Threshold performance was evaluated using receiver operating characteristic (ROC) analysis, bootstrap internal validation, decision curve analysis (DCA), treatment-stratified analyses, and sensitivity analyses. Results Chronic ITP developed in 86 children (25.7%). Chronicity decreased across platelet count rise-rate quartiles from 63.1% in Q1 to 3.6% in Q4 ( P for trend < 0.001 ). After adjustment for demographic, clinical, laboratory, bleeding-related, and treatment-related factors, each 10 × 10 9 /L/week increase in platelet count rise rate was associated with lower odds of chronicity (adjusted odds ratio, 0.37; 95% confidence interval, 0.27–0.50; P < 0.001 ). The area under the ROC curve for a lower rise rate was 0.846 (95% confidence interval, 0.794–0.891), and the bootstrap optimism-corrected value was 0.833 (95% confidence interval, 0.779–0.883). The exploratory cutoff of ≤20.5 × 10 9 /L/week yielded 76.7% sensitivity, 77.5% specificity, 54.1% positive predictive value, and 90.6% negative predictive value; bootstrap cutoffs ranged from 18.6 to 22.4 × 10 9 /L/week. DCA showed net benefit across threshold probabilities of 10%–45%. Conclusions A lower 4-week platelet count rise rate was independently associated with 12-month chronicity in pediatric primary ITP. A rate above the exploratory cutoff may identify children at low chronicity risk and support follow-up stratification. External validation is required before clinical adoption, and the cutoff should complement comprehensive clinical assessment rather than guide treatment escalation alone.
No takes yet. Share an insight, caveat, or question.
Du et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: